Unrelated Donor Transplant Versus Immune Therapy in Pediatric Severe Aplastic Anemia

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2016
The purpose of this study is to determine the feasibility of comparing outcomes of patients treated de novo with immunosuppressive therapy (IST) versus matched unrelated donor (MUD) hematopoietic stem cell transplant (HSCT) for pediatric acquired severe aplastic anemia.
Epistemonikos ID: 66b447d2fececa8b90c7831753c137eb449d515d
First added on: May 17, 2024